Hillhouse Capital Advisors, LTD.
Hillhouse Capital Advisors is a hedge fund in Central with $28.59B assets under management.
Company profile
Website
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
SEC advisor number
801-77363
FINRA CRD number
166112
AUM ?
$28.59B
(as of 30 Apr 19)
Accounts
25
(as of 30 Apr 19)
Employees
88
(32 investment advisory or research)
Address
Hillhouse Capital Advisors
C/O DMS HOUSE, 20 GENESIS CLOSE
PO BOX 2587
GEORGE TOWN, GRAND CAYMAN
E9 KY1-1103
C/O DMS HOUSE, 20 GENESIS CLOSE
PO BOX 2587
GEORGE TOWN, GRAND CAYMAN
E9 KY1-1103
Office hours
Monday - Friday, 9 AM - 6 PM (HONG KONG TIME)
Phone
(345) 749-8643
| Owner | Title | From | %Ownership |
|---|---|---|---|
| Hillhouse Capital Group Limited | Shareholder | 10/2012 | > 75% |
| Zhang, Lei | President | 10/2012 | < 5% |
| Hornung, Richard, A. | Chief Compliance Officer | 10/2012 | < 5% |
| O'connell, Colm John | Director | 10/2012 | < 5% |
| Zhang, Lei | Shareholder | 12/2011 | > 75% |
| Hillhouse Capital Group Holdings Limited | Shareholder | 12/2011 | > 75% |
| Shen, Jun | Director | 07/2013 | < 5% |
| Zhang, Lei | Chief Investment Officer | 01/2019 | < 5% |
| Hornung, Richard, A. | General Counsel | 04/2013 | < 5% |
| Ma, Cuifang, (Tracy) | Chief Operating Officer | 01/2019 | < 5% |
| Fund structure | AUM | Fund type | |
|---|---|---|---|
| Hillhouse Capital Advisors, LTD. | $28.59B | ||
| Yhg Investment, L.P. | $1.26B | Hedge Fund | Master |
| Gaoling Yali Feeder, LTD. | Feeder | ||
| Erv Investment Fund, L.P. | $327.94M | Hedge Fund | |
| Hillhouse China Value Fund, L.P. | $3.08B | Hedge Fund | Master |
| Hillhouse China Value Feeder, LTD. | Feeder | ||
| Gaoling Fund, L.P. | $19.9B | Hedge Fund | Master |
| Gaoling Feeder II, LTD. | Feeder | ||
| Gaoling Feeder, LTD. | Feeder | ||
| Gaoling Feeder Uk, LTD. | Feeder |
Fund data
Regulatory AUM / Assets Under Management
Number of accounts
Number of employees
| Top 50 of 54 long holdings End of quarter 31 Dec 19 |
Value |
#Shares |
Prev Q |
Change %, QoQ |
|---|---|---|---|---|
| $985.72M | 46.69M | 50.52M | -7.6 | |
| $907.08M | 5.47M | 5.47M | 0 | |
| $656.75M | 2.35M | 1.57M | +50.3 | |
| $552.62M | 11.47M | 14.23M | -19.4 | |
| $470.57M | 6.92M | NEW | ||
| $461.02M | 15.5M | 12.33M | +25.8 | |
| $419.9M | 1.98M | 2.18M | -9.1 | |
| $419.41M | 11.91M | 16.12M | -26.1 | |
| $361.56M | 1.75M | 1.75M | 0 | |
| $330.15M | 8.73M | 11.15M | -21.7 | |
| $320.19M | 2.75M | 2.75M | 0 | |
| $190.21M | 10.22M | 12.83M | -20.4 | |
| $172.95M | 4.3M | 11.96M | -64.0 | |
| $169.66M | 3.96M | 3.5M | +12.9 | |
| $153.82M | 4.39M | 4.39M | 0 | |
| $143.25M | 4.68M | 4.68M | 0 | |
| $140.27M | 2.55M | 2.55M | 0 | |
| $124.65M | 4.59M | NEW | ||
| $120.53M | 1.5M | 1.5M | +0.4 | |
| $92.4M | 5.91M | 5.91M | 0 | |
| $73.14M | 603.21K | 2.76M | -78.2 | |
| $72.93M | 4.47M | 4.47M | 0 | |
| $71.14M | 975.99K | 975.99K | 0 | |
| $59.35M | 1.05M | 1.05M | 0 | |
| $54.96M | 1.12M | 1.21M | -7.2 | |
| $53.12M | 2.2M | 4.4M | -50.0 | |
| $44.14M | 136.4K | 261K | -47.7 | |
| $35.2M | 3.99M | 3.99M | 0 | |
| $35.15M | 855.31K | 855.31K | 0 | |
| $33.5M | 1.5M | 1.5M | 0 | |
| $33.19M | 798K | 798K | 0 | |
| $25.33M | 2.9M | 2.92M | -0.9 | |
| $25.09M | 949.43K | 949.43K | 0 | |
| $23.82M | 10.45M | 10.45M | 0 | |
| $20.97M | 1.9M | 1.87M | +1.5 | |
| $19.78M | 891.2K | 749.42K | +18.9 | |
| $18.68M | 456K | 456K | 0 | |
| $17.65M | 200K | NEW | ||
| $16.37M | 7.24M | 9.44M | -23.3 | |
| $13.36M | 350K | 350K | 0 | |
| $11.54M | 943.25K | 943.25K | 0 | |
| $10.25M | 178.6K | 178.6K | 0 | |
| $8.97M | 802.03K | 802.03K | 0 | |
| $8.81M | 4.84M | 4.84M | 0 | |
| $8.45M | 600K | NEW | ||
| $8.03M | 50K | NEW | ||
| $7.75M | 767.13K | 767.13K | 0 | |
| $6.05M | 71.35K | NEW | ||
| $5.72M | 75K | 75K | 0 | |
| $4.61M | 322.9K | 322.9K | 0 |
Holdings list only includes long positions.
Only includes long positions.
Calendar
22 Feb 20
31 Dec 20
News
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings
Ownership
SC 13D/A
Cellular Biomedicine Group, Inc.
21 Feb 20
SC 13G
Gossamer Bio, Inc.
14 Feb 20
SC 13G/A
Apellis Pharmaceuticals, Inc.
14 Feb 20
SC 13G
Bilibili Inc.
14 Feb 20
SC 13G
Beneficial ownership report
14 Feb 20
SC 13G/A
Kiniksa Pharmaceuticals, Ltd.
14 Feb 20
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
13F-HR
Quarterly holdings report by institutional manager
14 Feb 20
SC 13G
Viela Bio, Inc.
14 Feb 20
SC 13G/A
MOGU Inc.
14 Feb 20